Information on this company is supplied by EMIS which is part of Euromoney Institutional Investor plc, one of Europe's largest publishers and a constituent of the FTSE 250 index.
Full name: Baxter Mexico S.R.L. de C.V.
Previous name(s): Baxter, S.A. de C.V. ()
Legal Form: Limited Liability Company
Operational Status: Operational
Incorporation Date: 1948
Intravenous fluids, plastic bags for blood collection and disposables.
Baxter, founded in 1948 with the acquisition of Madom's Pharmaceutical from Baxter International Inc ., develops, manufactures and markets pharmaceutical products, medical devices and biotechnology products to treat hemophilia, immune disorders, infectious diseases, kidney ailments, trauma and other chronic and acute medical conditions. Also offers home delivery services and personal attention on the products and areas of specialization that drive, anywhere in the country. In Mexico, Baxter's corporateMore
|Company Tear Sheet|
|NAICS Industry Classification||✓|
|Share Price information||✕|
|Subsidiaries and Affiliates||✓|
|Key Financial Highlights||✕|
|Financial Performance Charts||✕|
|Latest M&A and ECM Deals||✕|
|EMIS Credit Analytics|
|EMIS Benchmark Score||✕|
- or -
EMIS company profiles are part of a larger information service that combines company, industry and country data and analysis for over 120 emerging markets on a unique information platform.
If you need broad and deep coverage of one or many countries, you may be interested in subscribing. Request a demonstration of our full service and one of our account managers will be in touch.